Discussion Widespread vaccination against COVID-19 has been the primary defence against COVID-19 risks, offering protection against severe illness23 24 as well as contributing to broader community immunity. The excess risks of COVID-19 for patients with CHD have previously been described in unvaccinated cohorts.3–5 We have quantified the reduction in the absolute risk of death and hospitalisation in CHD patients with COVID-19 associated with vaccination in England.